Natera Q2 revenue rises beats estimates on higher overall test volumes, raises 2026 outlook

Natera

06/08/2026 21:21

Overview
Genetic testing firm's Q2 revenue grew 38%, beating analyst expectations
Company raised 2026 annual revenue guidance by $100 mln at midpoint
Q2 net loss narrowed to $67 mln from $101 mln a year earlier

Outlook
Natera raises 2026 annual revenue guidance to $2.85 bln-$2.91 bln
Company expects 2026 gross margin of 64% to 66%
Natera forecasts positive cash flow for 2026

Result Drivers
TEST VOLUME GROWTH - Co said revenue increase was driven by higher overall test volumes, including a 22% rise in tests processed year-over-year
ONCOLOGY TEST EXPANSION - Oncology test volumes rose 57% year-over-year, with MRD oncology units posting the largest sequential increase to date
COST REDUCTION - Higher gross margin was attributed to increased revenue and continued progress in reducing cost of revenues for tests processed

Company press release: ID:nBw2wT2PPa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$752.80 mln
$660.69 mln (19 Analysts)
Q2 Loss Per Share
 
$0.47
 
Q2 Net Loss
 
$67 mln
 
Q2 Income from Operations
 
-$75.80 mln
 
Q2 Operating Expenses
 
$555.30 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 21 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Natera, Inc. is $285.00, about 3.8% above its August 5 closing price of $274.62

Reuters Recommended Reads
Aug 5 - Caris Life Sciences Q2 revenue rises 45% on the back of molecular profiling services
Aug 5 - Grail Q2 revenue rises 26%, net loss narrows 3%
Aug 4 - Personalis Q2 revenue rises 30%, beats estimates on expanded Medicare coverage

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)